Neurocrine Biosciences to Present at Growth Conference

Neurocrine Biosciences, a biopharmaceutical company, will present at the Canaccord Genuity 45th Annual Growth Conference.

The company’s stock has shown volatility in the past year, with a 52-week high of $154.87 and a low of $84.23.

Key Financial Metrics

• Current stock price: $132.90
• Price-to-earnings ratio: 38.75
• Price-to-book ratio: 4.82